News Channels

14 Mar 2017 MetrioPharm Announces Positive Top-Line Results from a Phase IIa Study in Moderate-to-Severe Psoriasis with its Oral Lead Compound MP1032
14 Mar 2017 twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate
14 Mar 2017 Vedantra Pharmaceuticals Announces a Joint Research Collaboration with Neon Therapeutics to Develop Cancer Vaccines
14 Mar 2017 First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration
14 Mar 2017 RepliCel's Phase 1 Clinical Trial for Hair Loss Succeeds in Meeting Primary Endpoints
14 Mar 2017 Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases
14 Mar 2017 New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior
14 Mar 2017 LSK BioPharma Announces Enrollment of First Patient in Phase 3 Apatinib Trial in Gastric Cancer
14 Mar 2017 AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
14 Mar 2017 Sunovion Submits Supplemental New Drug Application to FDA for Use of APTIOM® (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 Years of Age and Older
14 Mar 2017 First Patient Dosed in Phase 2 Trial Evaluating Transgene’s TG4010 in Combination With Opdivo® (Nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
14 Mar 2017 Repatha® (Evolocumab) Demonstrates Reduced Need For Apheresis In Patients With High LDL Cholesterol In Phase 3 Study
14 Mar 2017 Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®
14 Mar 2017 Novartis Kisqali® (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor
13 Mar 2017 TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction
13 Mar 2017 Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer at 2017 SGO Annual Meeting on Women’s Cancer
13 Mar 2017 ImmunoGen Presents Phase 1 Biopsy Expansion Cohort Data at the Society of Gynecologic Oncology Annual Meeting
13 Mar 2017 Daiichi Sankyo Enters Agreement with Heptares Therapeutics to Discover and Develop Novel, Small-Molecules for the Treatment of Pain
13 Mar 2017 Karyopharm Announces Partial Clinical Hold to Pause Enrollment in Selinexor Trials
13 Mar 2017 Bavarian Nordic Announces Collaboration to Evaluate CV301 and Tecentriq in Bladder Cancer

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top